Galcanezumab
Modify Date: 2024-01-17 14:59:14
Galcanezumab structure
|
Common Name | Galcanezumab | ||
|---|---|---|---|---|
| CAS Number | 1578199-75-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GalcanezumabGalcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1]. |
| Name | Galcanezumab |
|---|
| Description | Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Yvette N Lamb. Galcanezumab: First Global Approval. Drugs. 2018 Nov;78(16):1769-1775. |
| No Any Chemical & Physical Properties |